NVOS Novo Integrated Sciences Corp: Multiplikator forward rega marang pendapatan

Logo perusahaan publik Novo Integrated Sciences Inc (NVOS)

Entry into the business is restricted by strict HIPAA oversight and licensing, yet it is protected by IT integration. The forward P/S metric illustrates the valuation trend, where the value of 0.20 reflects this status. Novo Integrated Sciences (NVOS) generates revenue from patient diagnostics and treatment in the US and Canada. A lack of pricing power forces the company to compete via discounts due to the high elasticity of demand for medical services.

Novo Integrated Sciences, Inc. - Rasio kapitalisasi marang dodolan sing dikarepake NVOS (periode 04.07.2022 - 16.11.2024)

Rincian analitis perusahaan Novo Integrated Sciences (NVOS)

Analisis wiwitan perusahaan:Novo Integrated Sciences Inc NVOS
Produk sing diprodhuksi Novo Integrated Sciences Corp

This indicator reflects the ratio of the market value of Novo Integrated Sciences (NVOS) to projected revenue, allowing for an assessment of the premium paid for future income streams. By analyzing the firm's forward P/S, an investor can weigh market expectations against client base volatility risks and SEC regulatory pressure, which determines the long-term sustainability of the business valuation amid unstable financing for large-scale deals.

Pesaing utama

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|PGNY - Rasio rega marang prakiraan pendapatan|ARDT - Multiplikator Forward P/S|SEM: Multiplikator Forward P/S|astranahealth.com (ASTH) - Multiplikator Forward P/S|MD (mednax.com) - Multiplikator Forward P/S|Multiplikator Forward P/S usph.com|Multiplikator Forward P/S PNTG|Rasio kapitalisasi marang dodolan sing dikarepake Organogenesis Holdings|Multiplikator Forward P/S NUTX (nutexhealth.com)|Auna SA (AUNA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SBC: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Jeuveau EOLS|CYH (Community Health Systems Inc) - Multiplikator forward rega marang pendapatan|SKIN: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan MDWD|BTMD: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan The Joint Corporation (JYNT)|Multiplikator Forward P/S DocGo Inc (DCGO)|Rega forward marang dodolan P3 Health Partners, Inc.|Rasio kapitalisasi marang dodolan sing dikarepake gaintherapeutics.com (GANX)|EUDA: Multiplikator forward rega marang pendapatan|BMGL: Rasio rega marang prakiraan pendapatan|collplant.com (CLGN) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Cuprina Holdings|CCM (concordmedical.com) - Multiplikator Forward P/S|Multiplikator Forward P/S ASHS|Rasio rega marang prakiraan pendapatan MEDIROM (MRM)|ALBT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|DIH Holding US, Inc. - Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Carmell Therapeutics Corporation|NewGenIvf Corp - Multiplikator Forward P/S|ATI Physical Therapy, Inc. - Rasio rega marang pendapatan sing dikarepake|CMAX: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan KDLY|Multiplikator forward rega marang pendapatan MODV|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)